| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001071346A3 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 09/12/2002 | WO2001047509A3 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
| 09/12/2002 | WO2001045641A3 Inhibitors of thrombin induced platelet aggregation |
| 09/12/2002 | WO2001041753A3 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/12/2002 | WO2001041752A3 Use of isoform specific inhibitors of cgmp-dependent protein kinase for treatment of pain |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001034174A3 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 09/12/2002 | WO2001034126A9 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt) |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001020034A3 Methods and compositions for the screening of cell cycle modulators |
| 09/12/2002 | WO2001013933A9 Agents for the enhanced oxygen delivery in mammals |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | WO2001001996A9 Compositions and methods for treating or preventing osteoporosis |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129385 Medthods for improving long-term memory storage and retrieval |
| 09/12/2002 | US20020128599 Transdermal drug delivery devices having coated microprotrusions |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128419 Silane copolymer coatings |
| 09/12/2002 | US20020128326 Topical immunomodulating compositions for treatment of aids, hepatitis b&c, other infectious diseases, and cancer |
| 09/12/2002 | US20020128319 Abeta 42 lowering agents |
| 09/12/2002 | US20020128317 Administering diacerein or rhein to treat inflammatory and autoimmune conditions characterized by an increased IL-1 and or TNF alpha level |
| 09/12/2002 | US20020128314 Suppository comprising: a prostaglandin vasodilator; 15-hydroxyprostaglandindehydrogenase inhibitor: and a base material that is solid at room temperature and releases the components when inserted in the urethra, |
| 09/12/2002 | US20020128303 Injection with a photodynamic compound having tumor selective uptake which is activated at a particular light frequency; injection with a xanthenone-4-acetic acid or salt; exposing the tumor to light at the activation frequency |
| 09/12/2002 | US20020128302 Use of a CB1 receptor antagonist for the preparation of drugs useful in the treatment of appetency disorders, such as obesity associated with non-insulin- dependent diabetes and drug dependence |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128292 Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/12/2002 | US20020128291 Following surgery or trauma or resulting in ocular diseases associated with choroidal neovascularization, such as age related macular degeneration and histoplasmosis syndrome |
| 09/12/2002 | US20020128289 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 09/12/2002 | US20020128288 Useful in the treatment of chronic and acute pain. |
| 09/12/2002 | US20020128285 Topical delivery of a local anesthetic |
| 09/12/2002 | US20020128282 Method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs |
| 09/12/2002 | US20020128280 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 09/12/2002 | US20020128277 Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/12/2002 | US20020128276 Administering an estrogen agonist/ antagonist; lowering vaginal pH; treating an urinary tract infection; treating vaginal dryness, itching, undesired spasms, and vaginitis; treating undesired urinary frequency or incontinence |
| 09/12/2002 | US20020128273 Composition and method for treating the effects of diseases and maladies |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128259 Using a vasopressin antagonist such as conivaptan |
| 09/12/2002 | US20020128258 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
| 09/12/2002 | US20020128252 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128240 Treatment of hyperproliferative diseases using active vitamin D analogues |
| 09/12/2002 | US20020128227 Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128218 Therapeutic delivery compositions and methods of use thereof |
| 09/12/2002 | US20020128203 Methods of identifying inhibitory compounds and uses thereof |
| 09/12/2002 | US20020128202 Stimulation of bone growth with thrombin peptide derivatives |
| 09/12/2002 | US20020128191 Topical administration of ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein to reduce hyperemia, chemosis, mucous discharge, neovascularization or ulcer formation |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128178 Use of a growth hormone or a growth hormone secretagogue for promoting bone formation in an animal simultaneous with callus distraction |
| 09/12/2002 | US20020128176 Treatment of erectile dysfunctions with C-Type natriuretic polypeptide (CNP) as a monotherapy or in combination with phosphodiesterase inhibitors |
| 09/12/2002 | US20020128173 Method of treating or preventing migraine headaches |
| 09/12/2002 | US20020128171 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (NO) activity as measured in a standard gastric emptying assay |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127627 Measuring diacylglycerol acetyltransferase activity; obtain enzmatic substrate, expose to microsomes, terminate reaction, monitor triglyceride generation |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127542 Pharmaceutical compositions for treating tumour diseases |
| 09/12/2002 | US20020127540 Detecting modulators of bone morphogenic activities; obtain cells, incubate with modulator, monitor expression of reporter molecules, compare to control |
| 09/12/2002 | US20020127303 Used for multivitamin tablets, hard gelatin capsules, dry food and feed compositions and for enriching sugar |
| 09/12/2002 | US20020127287 Administering biologically active lipophilic ginkgolides and derivatives and food ingredient modulating phospholipid metabolism for protecting neuronal cells for therapy and prophylaxis of mental or neuronal disorders |
| 09/12/2002 | US20020127282 Utilized to preserve pharmaceutical, cosmetic and chemical specialty products against bacteria, fungi and algae |
| 09/12/2002 | US20020127254 Devices for local and systemic delivery of active substance and methods of manufacturing thereof |
| 09/12/2002 | US20020127243 Administering dietary supplement comprising soybean, mushroom and mung bean or extracts to ameliorate at least one effect of malignancy or viral infection |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127203 Polypeptide having phenylacetyl-coenzyme a ligase activity which has been isolated from culture; for production of penicillin |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | DE10111058A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten New pharmaceutical compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| 09/12/2002 | DE10111046A1 Cosmetic or dermatological preparations for treating or preventing pigmentation disorders, e.g. freckles or liver spots, containing active agent combination of alpha-lipoic acid and UV-A or UV-B absorber |
| 09/12/2002 | DE10111039A1 Verwendung von Wirkstoffkombinationen aus alpha-Liponsäure und dermatologisch verträglichen Substanzen, die Lichtabsorption im UV-A-Bereich und/oder UV-B-Bereich zeigen, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe der Symptome der intrinsischen und/oder extrinsischen Hautalterung sowie zur Behandlung und Prophylaxe der schädlichen Auwirkungen ultravioletter Strahlung auf die Haut Use of active compound combinations of alpha-lipoic acid and dermatologically acceptable substances which light absorption in the UV-A region and / or UV-B range show, for the preparation of cosmetic or dermatological preparations for the treatment and / or prophylaxis of the symptoms of intrinsic and / or extrinsic skin aging and for the treatment and prophylaxis of the harmful effects of becoming ultraviolet radiation on the skin |
| 09/12/2002 | DE10110772A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on anticholinergics and PDE IV inhibitors |
| 09/12/2002 | DE10110355A1 Bekämpfung von Nebenwirkungen Combat side effects |
| 09/12/2002 | DE10108851A1 Verwendung von 5'-substituierten Nukleosiden und/oder deren Prodrugs zur resistenzfreien Therapie von Infektionskrankheiten Use of 5'-substituted nucleosides and / or their prodrugs for the resistance-free therapy of infectious diseases |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2440141A1 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | CA2440100A1 New use |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439917A1 Compositions having improved bioavailability of eletriptan |
| 09/12/2002 | CA2439915A1 New pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists |
| 09/12/2002 | CA2439854A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439849A1 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | CA2439802A1 Immune response potentiation |
| 09/12/2002 | CA2439793A1 Composition for the treatment of diabetes mellitus |
| 09/12/2002 | CA2439779A1 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | CA2439691A1 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |